Target intelligence / Profile preview

trans-2,3-enoyl-CoA reductase pseudogene 1 (TECRP1)

Target
TECRP1
01

Overview

“Trans-2,3-enoyl-CoA reductase pseudogene 1” (TECRP1) does not correspond to a validated or studied gene, protein, or drug target in current scientific knowledge. The only existing molecule with similar nomenclature is the enzyme **trans-2,3-enoyl-CoA reductase** (abbreviation: TECR), which is a multi-pass membrane oxidoreductase located in the endoplasmic reticulum and acts as part of the fatty acid elongation cycle, crucial for the formation of long-chain and very-long-chain fatty acids. The “pseudogene” variant (TECRP1) referenced in the query appears to be a non-existent or uncharacterized, possibly erroneously named or hypothetical entry, and is not a therapeutic target[4][6]. If your intent was to refer to the functional enzyme or gene TECR, see above description and note this is distinct from the queried pseudogene concept. If you require information on known TECR pseudogenes, please provide additional context or alternative names, as TECRP1 does not match any standard entries.

Beyond the preview

Go deeper on trans-2,3-enoyl-CoA reductase pseudogene 1 (TECRP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on trans-2,3-enoyl-CoA reductase pseudogene 1 (TECRP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call